Angiotensin‐converting enzyme inhibitors vs placebo or no treatment
Cardiovascular mortality · patients with chronic heart failure with preserved ejection fraction
Angiotensin‐converting enzyme inhibitors (ACEIs) showed no clear difference in cardiovascular mortality (RR) compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
- Beta‐blockers and inhibitors of the renin‐angiotensin aldosterone system for chronic heart failure with preserved… 2021 · Cochrane Headline outcomes onlyRR 0.93 [0.61, 1.42]2 studies · 945 participantsModerate